Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade
Vitaly Ablamunits(Pfizer (United States)), Kevan C. Herold(Yale University)
Cited by 109
Related Papers
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
|Glycobiology|2005|823
Quantifying the effect of experimental perturbations at single-cell resolution
|Nature Biotechnology|2021|230
Type 2 Diabetes and Congenital Hyperinsulinism Cause DNA Double-Strand Breaks and p53 Activity in β Cells
|Cell Metabolism|2013|148
Quantifying the effect of experimental perturbations at single-cell resolution
|bioRxiv (Cold Spring Harbor Laboratory)|2019|36